Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 4 1

Status

Completed 3Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6

Conditions

Breast Neoplasms 6Colorectal Neoplasms 5Neoplasms 4Stomach Neoplasms 3Malnutrition 3Lung Neoplasms 3Diarrhea 3Uterine Cervical Neoplasms 2Mucositis 2Inflammation 2Enteritis 2Chalazion 2Carcinoma, Hepatocellular 2Thyroid Neoplasms 1Squamous Intraepithelial Lesions 1Smoldering Multiple Myeloma 1Radiation Injuries 1Psychological Well-Being 1Psoriasis Vulgaris 1Polycystic Ovary Syndrome 1Periampullary Carcinoma Nos 1Pelvic Neoplasms 1Pelvic Inflammatory Disease 1Papillomavirus Infections 1Ovarian Neoplasms 1Neoplasms, Second Primary 1Muscle Invasive Bladder Cancer (MIBC) 1Multiple Myeloma 1Motor Activity 1Monoclonal Gammopathy of Undetermined Significance 1

Interventions

Trastuzumab 625Paclitaxel 576Cyclophosphamide 555Docetaxel 484Capecitabine 401Letrozole 376Fulvestrant 326Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 184Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 138Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Breast Neoplasms × Probiotics × Clear all
NCT07607548 2026-05-26

Assessment of the Effect of Probiotic Supplementation on Proinflammatory Mechanisms Induced by Systemic Treatment in Women With Breast Cancer

Poznan University of Medical Sciences

Phase NA Completed
60 enrolled
Breast

Breast Neoplasms, Inflammation

NCT05562518 2026-04-30

GRACE

University Hospital, Ghent

Phase 4 Active not recruiting
160 enrolled
Breast

Breast Neoplasms

NCT06039644 2026-03-06

To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer

GenMont Biotech Incorporation

Phase NA Recruiting
100 enrolled
Breast

Breast Neoplasms

NCT06892093 2025-09-08

Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase NA Recruiting
308 enrolled
Breast

Breast Neoplasms, Diarrhea

NCT03358511 2020-05-21

Engineering Gut Microbiome to Target Breast Cancer

Mayo Clinic

Phase NA Completed
7 enrolled
Breast

Breast Neoplasms

NCT01723592 2017-06-06

Orall Administered Probiotics to Improve the Quality of the Vaginal Flora of Women With Breast Cancer and Chemotherapy.

Medical University of Vienna

Phase NA Completed
27 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡